Tomorrow Cardiovascular is the UK’s leading company for vascular imaging innovation and development. In collaboration with medical physicists, surgeons and nurses, our vascular scientists work closely with industry experts from the field of medicine, surgery, pharmaceuticals and medical imaging to continually develop new diagnostics and minimally invasive vascular technologies. By scanning over 80,000 patients a year, Tomorrow Cardiovascular is the ideal collaborator for any researcher.
Under the tutelage of Dr Steven Rogers, Tomorrow Cardiovascular have supported several large scale commercial and academic studies with numerous high-ranking publications and conference presentations. Our state of the art and welcoming labs are fully equipped to accommodate a variety of research studies including first-in-man, randomised control trials and product development or refinement.Our work has been included in multiple national and international guidelines and the generation of intellectual property that has been leveraged on the open market. We have extensive experience of working both within the UK’s national health service and across borders with other state systems in both the public and private space.
We have substantial sector leading research and innovation knowledge fostered through collaborations with organisations such as The University of Manchester,Manchester Metropolitan University, Manchester University NHS Foundation Trust,Northern Care Alliance NHS Foundation Trust and The Manchester AcademicVascular Research and Innovation Centre (MAVRIC).